Impact of tumor necrosis factor antagonist combination and anti-integrin therapies on body mass index in inflammatory bowel disease: A cross-sectional study

por Shehab, Mohammad, Alali, Ali, Al-Hindawi, Ahmed, Alsayegh, Abdulwahab, Aldallal, Usama, Abdullah, Israa, Albaghli, Abbas, Alrashed, Fatema, Alfadhli, Ahmad, Bessissow, Talat
Publicado 2023

Immunogenicity of BNT162b2 Vaccine Booster Dose in Patients With Inflammatory Bowel Disease Receiving Infliximab Combination Therapy: A Prospective Observational Study

por Shehab, Mohammad, Alrashed, Fatema, Alfadhli, Ahmad, Alsayegh, Abdulwahab, Aldallal, Usama, Alsayegh, Mariam, Cherian, Preethi, Alkhair, Irina, Thanaraj, Thangavel Alphonse, Channanath, Arshad, Dashti, Ali A., Albanaw, Anwar, Ali, Hamad, Abu-Farha, Mohamed, Abubaker, Jehad, Al-Mulla, Fahd
Publicado 2022